Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-27

Clinical Trial Update: Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the combination of cagrilintide and semaglutide in people with type 2 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cagrilintide (cagrilintide)
  • semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2023-07-27